|
End-of-day quote
Nasdaq
2026-09-04
|
5-day change | 1st Jan Change | ||
| 1.820 USD | -0.55% |
|
-1.89% | -79.84% |
| 09-08 | EnGene Therapeutics Inc. Provides Clinical Updates | CI |
| 09-08 | EnGene Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ENGN | End-of-day quote | |
CBOE
| ENGN | Real-time | |
|
Deutsche Boerse AG
| S0N0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 1.95 | 3.45 | 4.24 |
| Spread/Res. | -6.67% | -47.25% | -57.08% |
| Spread/Supp. | -0.00% | +26.39% | +21.33% |
| Support | 1.82 | 1.44 | 1.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ENGN Stock
- Charts enGene Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
